Roles of organic anion transporters in the renal excretion of perfluorooctanoic acid

Basic and Clinical Pharmacology and Toxicology

Volumn 103, Issue 1, 2008, Pages 1-8

  Nakagawa, Hatsuki ^a   Hirata, Taku ^b   Terada, Tomohiro ^c   Jutabha, Promsuk ^b   Miura, Daisaku ^b   Harada, Kouji H ^a   Inoue, Kayoko ^a   Anzai, Naohiko ^b   Endou, Hitoshi ^b   Inui, Ken Ichi ^c   Kanai, Yoshikatsu ^b   Koizumi, Akio ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYORIN UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ORGANIC ANION TRANSPORTER 1; ORGANIC ANION TRANSPORTER 2; ORGANIC ANION TRANSPORTER 3; PERFLUOROOCTANOIC ACID;

ARTICLE; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SPECIES DIFFERENCE; TOXICOKINETICS; URINARY EXCRETION;

ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE; FLUOROCARBONS; HUMANS; KIDNEY; KIDNEY TUBULES, PROXIMAL; OCTANOIC ACIDS; ORGANIC ANION TRANSPORT PROTEIN 1; ORGANIC ANION TRANSPORTERS, SODIUM-INDEPENDENT; RATS; SPECIES SPECIFICITY; TRANSFECTION;

ANIMALIA; AVENA; RATTUS;

EID: 45749152051     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2007.00155.x     Document Type: Article

References (34)

1. Kissa E. Fluorinated Surfactants and Repellents, 2nd ed. Marcel Dekker, New York, 2001.
2. Office of Pollution Prevention and Toxics. Preliminary Risk Assessment of the Developmental Toxicity Associated with Exposure to Perfluorooctanoic Acid and Its Salts. U.S. Environmental Protection Agency, Washington, DC, 2003.
3. Abdellatif AG, Preat V, Taper HS, Roberfroid M. The modulation of rat liver carcinogenesis by perfluorooctanoic acid, a peroxisome proliferator. Toxicol Appl Pharmacol 1991 111 : 530 7.
4. Lau C, Thibodeaux JR, Hanson RG, Narotsky MG, Rogers JM, Lindstrom AB et al. Effects of perfluorooctanoic acid exposure during pregnancy in the mouse. Toxicol Sci 2006 90 : 510 8.
5. Sohlenius AK, Lundgren B, DePierre JW. Perfluorooctanoic acid has persistent effects on peroxisome proliferation and related parameters in mouse liver. J Biochem Toxicol 1992 7 : 205 12.
6. Intrasuksri U, Rangwala SM, O'Brien M, Noonan DJ, Feller DR. Mechanisms of peroxisome proliferation by perfluorooctanoic acid and endogenous fatty acids. Gen Pharmacol 1998 31 : 187 97.
7. Upham BL, Deocampo ND, Wurl B, Trosko JE. Inhibition of gap junctional intercellular communication by perfluorinated fatty acids is dependent on the chain length of the fluorinated tail. Int J Cancer 1998 78 : 491 5.
8. Yang Q, Abedi-Valugerdi M, Xie Y, Zhao XY, Möller G, Nelson BD et al. Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome proliferator, perfluorooctanoic acid. Int Immunopharmacol 2002 2 : 389 97.
9. 2+ currents in guinea-pig ventricular myocytes. Biochem Biophys Res Commun 2005 329 : 487 94.
10. Matsubara E, Harada K, Inoue K, Koizumi A. Effects of perfluorinated amphiphiles on backward swimming in Paramecium caudatum. Biochem Biophys Res Commun 2006 339 : 554 61.
11. Olsen GW, Burris JM, Ehresman DJ, Froehlich JW, Seacat AM, Butenhoff JL et al. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexansulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Persp 2007 115 : 1298 1305.
12. Kudo N, Katakura M, Sato Y, Kawashima Y. Sex hormone-regulated renal transport of perfluorooctanoic acid. Chem Biol Interact 2002 139 : 301 16.
13. Kudo N, Kawashima Y. The Study of Excretion Pathway and Long-Term Persistency of Fluorinated Fatty Acids in Primates. Annual Reports of the Primate Research Institute, Kyoto University, Inuyama, Aichi, 2001.
14. Butenhoff J, Costa G, Elcombe C, Farrar D, Hansen K, Iwai H et al. Toxicity of ammonium perfluorooctanoate in male cynomolgus monkeys after oral dosing for 6 months. Toxicol Sci 2002 69 : 244 57.
15. Vanden Heuvel JP, Kuslikis BI, Van Rafelghem MJ, Peterson RE. Tissue distribution, metabolism, and elimination of perfluorooctanoic acid in male and female rats. J Biochem Toxicol 1991 6 : 83 92.
16. Buist SC, Cherrington NJ, Choudhuri S, Hartley DP, Klaassen CD. Gender-specific and developmental influences on the expression of rat organic anion transporters. J Pharmacol Exp Ther 2002 301 : 145 51.
17. Ljubojevic M, Balen D, Breljak D, Kusan M, Anzai N, Bahn A et al. Renal expression of organic anion transporter OAT2 in rats and mice is regulated by sex hormones. Am J Physiol Renal Physiol 2007 292 : F361 72.
18. Harada K, Inoue K, Morikawa A, Yoshinaga T, Saito N, Koizumi A. Renal clearance of perfluorooctane sulfonate and perfluorooctanoate in humans and their species-specific excretion. Environ Res 2005 99 : 253 61.
19. Cha SH, Sekine T, Fukushima JI, Kanai Y, Kobayashi Y, Goya T et al. Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney. Mol Pharmacol 2001 59 : 1277 86.
20. Sekine T, Watanabe N, Hosoyamada M, Kanai Y, Endou H. Expression cloning and characterization of a novel multispecific organic anion transporter. J Biol Chem 1997 272 : 18526 9.
21. Enomoto A, Takeda M, Shimoda M, Narikawa S, Kobayashi Y, Kobayashi Y et al. Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors. J Pharmacol Exp Ther 2002 301 : 797 802.
22. Kusuhara H, Sekine T, Utsunomiya-Tate N, Tsuda M, Kojima R, Cha SH et al. Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain. J Biol Chem 1999 274 : 13675 80.
23. Hosoyamada M, Sekine T, Kanai Y, Endou H. Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney. Am J Physiol 1999 276 : F122 8.
24. Takeda M, Tojo A, Sekine T, Hosoyamada M, Kanai Y, Endou H. Role of organic anion transporter 1 (OAT1) in cephaloridine (CER)-induced nephrotoxicity. Kidney Int 1999 56 : 2128 36.
25. Sweet DH, Wolff NA, Pritchard JB. Expression cloning and characterization of ROAT1. The basolateral organic anion transporter in rat kidney. J Biol Chem 1997 272 : 30088 95.
26. Sweet DH, Miller DS, Pritchard JB, Fujiwara Y, Beier DR, Nigam SK. Impaired organic anion transport in kidney and choroid plexus of organic anion transporter 3 (Oat3 (Slc22a8)) knockout mice. J Biol Chem 2002 277 : 26934 43.
27. Motohashi H, Sakurai Y, Saito H, Masuda S, Urakami Y, Goto M et al. Gene expression levels and immunolocalization of organic ion transporters in the human kidney. J Am Soc Nephrol 2002 13 : 866 74.
28. Andersen ME, Clewell HJ 3rd, Tan YM, Butenhoff JL, Olsen GW. Pharmacokinetic modeling of saturable, renal resorption of perfluoroalkylacids in monkeys-probing the determinants of long plasma half-lives. Toxicology 2006 227 : 156 64.
29. Gotoh Y, Kato Y, Stieger B, Meier PJ, Sugiyama Y. Gender difference in the Oatp1-mediated tubular reabsorption of estradiol 17beta-D-glucuronide in rats. Am J Physiol Endocrinol Metab 2002 282 : E1245 54.
30. Kato Y, Kuge K, Kusuhara H, Meier PJ, Sugiyama Y. Gender difference in the urinary excretion of organic anions in rats. J Pharmacol Exp Ther 2002 302 : 483 9.
31. Ekaratanawong S, Anzai N, Jutabha P, Miyazaki H, Noshiro R, Takeda M et al. Human organic anion transporter 4 is a renal apical organic anion/dicarboxylate exchanger in the proximal tubules. J Pharmacol Sci 2004 94 : 297 304.
32. Anzai N, Kanai Y, Endou H. Organic anion transporter family: current knowledge. J Pharmacol Sci 2006 100 : 411 26.
33. 14C]perfluorooctanesulfonate. Fundam Appl Toxicol 1984 4 : 972 6.
34. Harada KH, Hashida S, Kaneko T, Takenaka K, Minata M, Inoue K et al. Biliary excretion and cerebrospinal fluid partition of perfluorooctanoate and perfluorooctane sulfonate in humans. Environ Toxicol Pharmacol 2007 24 : 134 9.